Background: The structural and catalytic similarities between modular nonribosomal peptide synthetases (NRPSs) and polyketide synthases (PKSs) inspired us to search for a hybrid NRPS^PKS system. The antitumor drug bleomycin (BLM) is a natural hybrid peptide^polyketide metabolite, the biosynthesis of which provides an excellent opportunity to investigate intermodular communication between NRPS and PKS modules. Here, we report the cloning, sequencing, and characterization of the BLM biosynthetic gene cluster from Streptomyces verticillus ATCC15003.
Introduction
Nonribosomal peptides and polyketides are two large families of natural products that include many clinically valuable drugs, such as vancomycin and erythromycin (antibacterial), cyclosporin and FK506 (immunosuppresant), and bleomycin (BLM) and epothilone (antitumor). The biosyntheses of nonribosomal peptides and polyketides are catalyzed by nonribosomal peptide synthetases (NRPSs) and polyketide synthases (PKSs), respectively. NRPSs and PKSs use a very similar strategy for the assembly of these two distinct classes of natural products by sequential condensation of amino acids and short carboxylic acids, respectively, and utilize the same 4P-phosphopantethein prosthetic group to channel the growing peptide or polyketide intermediates during the elongation processes. Both NRPSs and type I PKSs are multifunctional proteins that are organized into modules. (A module is de¢ned as a set of distinctive domains catalyzing all the steps for one cycle of peptide or polyketide chain elongation and associated modi¢cations.) The number and order of modules and the type of domains within a module on each NRPS or PKS protein determine the structural variations of the resulting peptide and polyketide products by dictating the number, order, choice of the amino acid or carboxylic acid to be incorporated, and the modi¢cations associated with a particular cycle of elongation [1^5] . These striking structural and catalytic similarities between NRPS and PKS inspired us [6] and others [7^12] to search for hybrid NRPS^PKS systems that integrate both NRPS and PKS modules. Since the modular architecture of both NRPS [13^18] and PKS [1^3,19^21] has been exploited successfully in combinatorial biosynthesis of diverse`unnatural' natural products, it is imagined that hybrid NRPS^PKS systems, capable of incorporating both amino acids and short carboxylic acids into the ¢nal products, could lead to even greater chemical structural diversity.
The BLMs, a family of antitumor antibiotics produced by Streptomyces verticillus, have been the focus of intensive inquiry for more than three decades [22] . Differing structurally at the C-terminal amines of the glycopeptides, the BLMs are incorporated into current chemotherapy of several malignancies under the trade name of Blenoxane 0 that contains BLM A2 and B2 as the principal constituents ( Figure 1A ) [23] . Closely related to the BLMs are the phleomycins, the 5,5P-dihydro-analogs of BLMs. The BLMs are thought to exert their biological effects through a metal-dependent oxidative cleavage of DNA and possibly also of RNA in the presence of molecular oxygen [22] . However, wide application of this agent has been prevented by early development of drug resistance and by the dose-limiting pulmonary toxicity. Consequently, there have been continuing attempts to develop new BLM congeners to de¢ne the functional roles of the individual subunits and to search for drugs with better clinical ef¢cacy and lower toxicity.
The biosynthesis of BLMs has been extensively studied by feeding isotope-labelled precursors and by isolating various biosynthetic intermediates and shunt metabolites [232 7] . These results unambiguously established the hybrid peptide^polyketide origin of BLMs, the aglycone of which is derived from nine amino acids, one acetate, and two Sadenosylmethionines (AdoMet). Driven by the belief that novel congeners could be generated by manipulating genes governing antibiotic production, attempts to clone the gene cluster for BLM biosynthesis were initiated by Sugiyama and co-workers [28] and by Calcutt and Schmidt [29] , who both cloned the blm resistance genes from S. verticillus ATCC15003 in 1994, respectively.
We set out to clone the BLM gene cluster to shed light on hybrid peptide^polyketide biosynthesis, aside from its utilities in generating novel BLM congeners through combinatorial biosynthesis [6] . On the assumption that BLM biosynthesis follows the paradigm for peptide and polyketide biosynthesis, we reasoned that the Blm megasynthetase, which catalyzes the assembly of the BLM backbone from the amino acid and short carboxylic acid precursors, should bear the characteristics of both NRPS and PKS, providing a model to study the mechanism by which NRPS and PKS could be integrated into a productive biosynthetic system to synthesize a hybrid peptide^polyke-tide metabolite ( Figure 1B ). Here we report the cloning, DNA sequence analysis, and biochemical characterization of the blm biosynthetic gene cluster from S. verticillus ATCC15003. Our studies revealed several unprecedented features for hybrid peptide^polyketide biosynthesis, setting the stage to investigate the molecular basis for intermodular communication between NRPS and PKS, and supported the wisdom of combining individual NRPS and PKS modules for combinatorial biosynthesis to make novel`unnatural' natural products from amino acids and short carboxylic acids.
Results
Cloning and identi¢cation of the blm gene cluster from S. verticillus ATCC15003 Sugiyama and co-workers previously cloned two BLM resistance genes, blmAB, from S. verticillus ATCC15003 [28] . Extensive biochemical and structural characterizations established that BlmA is a BLM-binding protein, conferring BLM resistance by drug sequestering [30, 31] , and that BlmB is a BLM N-acetyltransferase, inactivating BLM by N-acetylation of BLM at the primary amine of L-aminoalaninamide moiety in the presence of acetyl coenzyme A (CoA) [28, 32, 33] . Subsequently, Calcutt and Schmidt sequenced a 7.2-kb DNA fragment £anking the blmAB genes, revealing seven open reading frames (orfs) [29] , however, none of which were found to encode putative NRPS or PKS enzymes ( Figure 2B ). Given the precedent that antibiotic production genes commonly occur as a cluster in actinomycetes [1] , we set out to isolate the DNA £anking the blmAB resistance locus in order to identify the blm biosynthetic gene cluster. An S. verticillus ATCC15003 genomic library was constructed in the Escherichia coliŜ treptomyces shuttle vector pOJ446 [34] and was ¢rst screened with probes made from both ends of the blmAB locus [29] (Figure 2A , probe-1 and -2), resulting in the isolation of overlapping cosmids extending from this locus. These experiments were then repeated with probe-3 and probe-4 made from the ends of the newly isolated cosmids, leading to the localization of a 140-kb contiguous region of DNA, covered by 16 overlapping cosmids as represented by pBS4 to pBS11 (Figure 2A ). The entire 140-kb region was next analyzed by Southern hybridization under various conditions with heterologous NRPS probes to screen for putative NRPS genes. The heterologous NRPS probes were prepared from the three putative NRPS gene clusters isolated previously from S. verticillus ATCC15003, none of which was clustered with the blmAB resistance locus [6] . While no signal was detected from the 40-kb DNA region downstream of the blmAB genes, weak signals were evident at a low stringency hybridization condition from the cosmids within the 100-kb DNA region upstream of the blmAB genes [6] . The latter result prompted us to determine the approximately 77.5-kb DNA sequence of this region, covered by pBS5, pBS6, and pBS8, directly upstream of the 7.2-kb blmAB locus (Figure 2A ).
Nucleotide sequence analysis of the blm cluster
The sequenced region was analyzed by the CODONPRE-FERENCE method available in the GCG software and revealed 40 orfs^only 30 of them are discussed in this paper ( Figure 2B ). The overall GC content of the sequenced region is 75.1%, characteristic for Streptomyces species [35] . Preliminary functional assignments of individual orfs were made by comparison of the deduced gene products with proteins of known functions in the database. Among the orfs identi¢ed from the cloned cluster, we found (1) one PKS gene (blmVIII), (2) 10 NRPS genes (blmX, blmIX, blmVII, blmVI, blmV, blmIV, blmIII, blmI, blmII, blmXI), one of which, blmI, has been previously characterized to encode a type II peptidyl carrier protein (PCP) [36] , (3) ¢ve sugar biosynthesis genes (blmC, blmD, blmE, blmF, blmG), and (4) genes encoding other biosynthesis enzymes as well as resistance and regulatory genes ( Table 1 ).
All the orfs between orf30 and orf7 are transcribed in the same direction, while the orfs at both sides of orf30-orf7 are transcribed in opposite directions. Possible promoter regions are assumed to have been identi¢ed upstream of orf30, orf28, and blmV ( Figure 2B ). While the boundaries of the blm gene cluster are yet to be determined by experiments, it is reasonable to propose that orf30 and orf7 rep- [29] , blm genes reported in this paper (black), and orfs sequenced but not discussed (blue). (B) Genetic organization of the BLM biosynthetic gene cluster. Proposed functions for individual orfs are summarized in Table 1 . Color coding indicates NRPS genes (red), PKS gene (green), sugar biosynthesis gene (blue), and all other genes (black). Modules for individual NRPS and PKS are given along with their proposed substrates in parentheses.
resent the left-and right-hand ends of the blm cluster, respectively, on the basis of sequence analysis. blmX, blmIX, blmVIII, blmVII, and blmVI are likely translationally coupled, as judged by their overlapping stop and start codons, suggesting that they may form part of the same operon. Similarly, blmV, blmG, orf18, blmIV, blmIII, orf15, blmII, orf13, blmE, blmD, blmI, blmC, orf8, and orf1 may form another operon, as judged by their overlapping stop and start codons or by the lack of apparent transcriptional terminator in the short intergenic regions between blmG and blmF (13 bp), orf18 and blmIV (84 bp), and orf13 and blmE (70 bp). Similar operon-type organizations for both NRPS and PKS genes are well known and have been postulated to facilitate cotranslation of the genes within the operon to yield equimolar amounts of proteins for optimal interactions to form the functional NRPS megasynthetases or PKS megasynthetases [1] .
The blm NRPS genes
The blmIII, blmIV, blmV, blmVI, blmVII, blmIX, and blmX genes encode modular NRPSs consisting of domains characteristic for known NRPSs, such as the adenylation (A) domain [37] , PCP [38] , condensation (C) domain [39] , as well as thiazole-forming speci¢c domains, such as the condensation/cyclization (Cy) domain [11, 40] and the oxidation (Ox) domain [11] ( Table 1) . The most conserved amino acid motifs for these domains are shown in Figure 3 (AF ). BlmVI is unique among all the Blm NRPSs identi¢ed. Its N-terminal module (NRPS-5) consists of an unusual domain that bears a close resemblance to a family of acyl CoA ligases (ALs) (Figure 3E ), such as the Mycobacterium bovis AL (53% similarity and 38% identity) [41] , and an acyl carrier protein (ACP)-like domain, such as the one found in EPOS C (47% similarity and 30% identity) [11] also known as EpoD [12] . These data suggest that Conserved motifs [4, 5] NRPS-5 unlikely acts as an NRPS module and hence is named as a starter module, presumably involved in the biosynthesis of the L-aminoalaninamide moiety of BLM. Also noteworthy is the C domain of NRPS-3 that lacks both His residues of the conserved HHxxxDG active site for transpeptidation (C3, Figure 3C ) [39] .
The blmI, blmII, and blmXI genes encode NRPSs with an unusual architecture. In contrast to the aforementioned modular NRPSs consisting of multiple domains, BlmI (Figure 3B) , BlmII, and BlmXI ( Figure 3C ) are discrete proteins homologous to individual domains of type I NRPSs. We have previously characterized BlmI as a type II PCP [36] .
The blm PKS gene
The blmVIII gene encodes a PKS module consisting of a ketoacyl synthase (KS), an acyltransferase (AT), a methyltransferase (MT), a ketoreductase (KR), and an ACP domain [1] . The KS domain is highly homologous to all known KSs, including the active site Cys, as well as the two highly conserved His residues [42^45]. However, it displays lower similarity to the KSs from Streptomyces than to a particular set of KS domains from other bacteria, such as EPOS B (68% similarity and 55% identity) [11] ^also known as EpoC [12] ^or MtaD (68% similarity and 50% identity) [10] . Close examination of the latter family of sequences revealed that it contains all the KS domains known to interact with NRPS modules in hybrid NRPSP KS systems [8^12,46^49]. The AT domain is predicted to be speci¢c for malonyl CoA, on the basis of sequence comparison with ATs of known substrate speci¢city [50] , indicative that the PKS module uses malonyl CoA as the preferred extender unit ( Figure 4A ). The latter is consistent with early feeding experiments that established that the 15P-CH 3 group is derived from methionine, presumably via an AdoMet-dependent MT [26, 27] . A candidate for the latter enzyme activity, an MT domain, is identi¢ed between the AT and KR domain. The MT domain contains the three core motifs of AdoMet-dependent MTs [51] , and is highly homologous to other MT domains of PKS, such as the one found in EPOS D (47% similarity and 32% identity) [11] ^also known as EpoE [12] ( Figure  4B ). The KR domain shows signi¢cant homology to known KR domains, such as the one found in MtaB (43% similarity and 31% identity) [10] and EPOS C (44% similarity and 34% identity) [11] ^also known as EpoD [12] , with the signature NADPH binding site of GxGxxGxxxA [52] . The last domain of the PKS module is an ACP, with its signature motif around the highly conserved 4P-phosphopantethein attachment site Ser residue [53] . Intriguingly, this ACP domain exhibits the greatest similarity to PCP, such as the one found in pristinamycin I synthetase (58% similarity and 46% identity) [54] , rather than ACPs, such as the one found in EPOS A (45% similarity and 32% identity) [11] ^also known as EpoA [12] (Figure 4C ).
Sugar biosynthesis genes
Five putative sugar biosynthesis genes, blmC, blmD, blmE, blmF, and blmG, are identi¢ed within the blm gene cluster.
The deduced blmC gene product shows a high degree of similarity to a family of NDP-sugar synthases, such as RfaE [8, 47, 48] ; LDKS, LNKS [85] ), and ACP or PCP domains (EPOS A-ACP, EPOS B-ACP, EPOS P-PCP [11] ; HMWP1-ACP, HMWP2-PCP [8, 47, 48] ). BlmVIII-AT resembles to malonyl CoA-speci¢c ATs (boxed) and BlmVIII-ACP resembles to PCPs (boxed).
(50% similarity and 37% identity) [55] . The gene product of blmD is closely related to a family of carbamoyl transferases, such as MmcS (45% similarity an 33% identity) [56] . BlmE strongly resembles a family of glycosyl transferase, such as RfaF (45% similarity and 29% identity) [57] . The deduced product of blmF appears to be bifunctional. The N-terminal part of BlmF (1^250 amino acids) exhibits low similarity to several glycosyl transferases, such as Cps14I (37% similarity and 26% identity) [58] . The C-terminal part of BlmF (300^494 amino acids) shows low similarity to BlmORF1 [29] and to the catalytic domain of bovine Asp/Asn L-hydroxylase (44% similarity and 35% identity) [59] . BlmORF1 has been proposed by Calcutt and Schmidt as the putative His L-hydroxylase [29] , although we were unable to demonstrate this activity in vitro using P-6m as a substrate [6] . The blmG gene product shows strong homology to various sugar epimerases, such as YtcB (44% similarity and 28% identity) [60] .
Resistance, regulatory, and other genes Antibiotic production genes have been found nearly in all cases to be clustered in one region of the bacterial chromosome, consisting of structural, resistance, and regulatory genes. Two resistance genes, blmAB, have been characterized previously, which confer BLM resistance to the producing organism by drug sequestering (BlmA) or modi¢ca-tion (BlmB) [28^33] . In addition, BlmORF7 has also been proposed to be a member of the ATP-binding cassette (ABC) transporter family of proteins [29] . The latter proteins confer resistance to the producing organisms by transporting the drug out of the cells [61] , although this function could not be proved for BlmORF7 by Calcutt and Schmidt [29] . The gene product of ORF29 is closely related to a family of transmembrane transporters, such as YchM (42% similarity and 31% identity) [62] , suggesting that ORF29 could also be involved in BLM resistance by drug transporting. Multiple mechanisms for drug resistance are common for many antibiotic-producing organisms [56, 63] .
Antibiotic production in Streptomyces appears to be regulated in response to nutritional status and a variety of environmental conditions. Pathway speci¢c regulatory genes have been identi¢ed in several of the known gene clusters [64] . At least, two genes that may be involved in regulation of BLM biosynthesis in S. verticillus ATCC15003 are identi¢ed. ORF15 shows a high degree of similarity to SyrP (52% similarity and 37% identity) that participates in a phosphorylation cascade controlling syringomycin production [65] , and ORF30 resembles a family of metal-responsive repressors, such as SmtB (52% similarity and 40% identity) [66] .
The remaining genes identi¢ed within the blm cluster are orf8, 13, 18 and 28. The gene product of orf8 shows a high sequence homology to a family of oxidases, such as Yqe-R (48% similarity and 28% identity) [67] . The orf18 product resembles known asparagine synthetases, such as AsnB (43% similarity and 38% identity) [68] . orf28 encodes a protein similar to several phosphatidylserine decarboxylases, such as Mth1026 (45% similarity and 29% identity) [69] . It is not clear what role such a protein could play in BLM biosynthesis. Finally, no function could be predicted for orf13. The deduced product of orf13 resembles MbtH (65% similarity and 42% identity), which is a protein with unknown function found in the mycobactin gene cluster [70] .
Predictions of amino acid speci¢city of Blm NRPSs
Marahiel and co-workers have recently postulated the speci¢city-conferring codes for A domains of NRPS by comparing the sequence of the A domain of gramicidin synthetase A, PheA, with 160 other A domains of NRPS modules [18] . These codes, consisting of 10 residues that putatively form the amino acid binding pockets, provide a structural basis of substrate recognition in the A domains of NRPSs and could be used to predict from the primary sequence the speci¢city of biochemically uncharacterized A domains. Using these codes, we were able to predict the amino acid speci¢city for NRPS module 0 (Cys), 1 (Cys), 3 (Asn), 4 (Ser), 6 (Thr), and 9 (Asn) ( Table 2 ), but not for NRPS module 2, 7, and 8, the codes of which do not match to any of those de¢ned by Marahiel and co-workers. Since the amino acid precursors for BLM biosynthesis have been established early by feeding experiments, the remaining three amino acid residues are L-Ala, Ala, and His, whose codes were either not available (L-Ala and His) or poorly de¢ned (Ala) in Marahiel and co-workers' original work [18] . To update the existing codes, we performed additional sequence analysis to de¢ne the code assignments for the L-Ala and His binding pockets and to re¢ne the code assignments for the Ala binding pockets.
The same strategy used by Marahiel and co-workers was adopted in the current work (During the review of this manuscript, a similar approach to predict the substrate speci¢city of A domains of NRPSs was published by Townsend and co-workers [71] . Although the two groups use a slightly different set of amino acid residues to de¢ne the substrate binding pockets of A domains, both methods were based on the same X-ray structure of PheA [72] and yield consistent predictions.) The selectivity-conferring residues that constitute the codes were determined by comparing the primary amino acid sequences of the A domains of the Blm NRPS modules with those in the current GenBank database. NRPS-2 was found to be most related to the Ebony protein from Drosophila and the second module of FxbB from Mycobacterium smegmatis. Ebony is involved in the biosynthesis of L-alanyl-dopamine and has been proposed to activate L-Ala [73] . FxbB is involved in exochelin biosynthesis, also activating L-Ala [74, 75] . On the basis of these three proteins, we now de-¢ne a code assignment for the L-Ala binding pocket, predicting that NRPS-2 speci¢es for L-Ala (Table 2 ). It is noteworthy that the acidic residue Asp-235, which is conserved in all K-amino acid-activating codes, is changed into Val-235 in the newly de¢ned code for L-Ala. Asp-235 and Lys-517 have been proposed to mediate key interactions with the K-amino group and the carboxyl group of the substrate, respectively, and are therefore essential for activating an K-amino acid [18] . The Asp235Val alteration in the L-Ala code is consistent with a L-amino acid substrate. Similar mutations at Asp-235 have been noted for a few other NRPSs activating substrates that do not have an Kamino group, such as AcvA for the g-carboxyl group of Kaminoadipic acid, EntE for 2,3-dihydroxy benzoic acid, and YbtE for salicylic acid [18] .
NRPS-8 was found to be closely related to the third module of BacC, which activates His [40] . Although this is the only additional domain known to activate His, we would like to put forward the code assignment for the His binding pocket, suggesting that NRPS-2 speci¢es for His (Table 2). NRPS-7 was found to be most related to the second module of the McyA protein for microcystin biosynthesis from Microcystis aeruginosa, which was proposed to activate Ala [76] , and the second module of the SafB protein, SafB-2, for saframycin biosynthesis from Myxococcus xanthus, which was proposed to activate Gly [77] . Since the only amino acid precursor common to BLM and saframycin biosynthesis is Ala, we questioned if the original assignments of amino acid speci¢city for each module of the SafAB proteins^SafB-1 for Ala, SafB-2 for Gly, SafA-1 for Tyr, and SafA-2 for Tyr^were incorrect. Close examination of the original work revealed that these assignments, in fact, were based mainly on the colinearity rule [77] , rather than on rules for substrate recognition [18] . Since many exceptions to the colinearity rule have been noted recently [75, 78, 79] , we re-examined the SafAB sequence and found that SafB-1 showed signi¢cant homology to NRPS-5 and a group of ALs, such as the AL of M. bovis (53% similarity and 38% identity) ( Figure 3E ) [41] . SafA-1 is closely related to the Gly-activating modules from Ta1 [9] and CdaPSII [80] , from which a new code assignment for the Gly binding pocket is derived (Table 2 ). This leaves SafB-2 as the only candidate for Ala activation, despite the fact that it does not agree with the known code for Ala derived from two fungal NRPSs [18] . Taken together these data, we propose that both NRPS-7, McyA-2, and SafB-2 activate Ala, de¢ning a second code assignment for the Ala binding pockets (Table 2) . Multiple codes of A domains, analogous to codon degeneracy for protein biosynthesis, have been observed for several amino acids, such as Leu (four codes), Tyr (three codes), and Val (three codes) [18] . Table 2 Predictions of substrate speci¢city of Blm NRPSs based on the speci¢city-conferring codes of A domains (shown in bold) [18] . Domain  235  236  239  278  299  301  322  330  331  517 Similarity
a Similarity is calculated by BestFit in the GCG program [93] . b Amino acid speci¢city conferring codes of A domains de¢ned in this work, and X indicates a variable amino acid within the determined code.
Speci¢c adenylation of Cys by NRPS-1 and Thr by NRPS-6
While sequence analysis based on the speci¢city conferring codes of A domains in NRPSs allowed us to predict the substrates for all the Blm NRPS modules, accounting for all nine amino acids required for BLM biosynthesis, we set to verify these predictions by biochemical characterization of the NRPS modules. The latter strategy has been hampered by either the lack of expression of the desired genes or the poor solubility of the resultant proteins in heterologous hosts such as E. coli and Streptomyces lividans. However, we were successful in overexpressing the A domains from both the NRPS-1 and NRPS-6 modules in E. coli. The recombinant proteins were puri¢ed ( Figure 5A ), and their substrate speci¢cities were examined according to the amino acid-dependent ATP^PPi assay [36] . NRPS-1A and NRPS-6A activate speci¢cally L-Cys and L-Thr, respectively, among the amino acids tested ( Figure 5B ), providing experimental evidence for the sequence-based predictions.
Bioconversion of BLM aglycone into BLMs in S. lividans S. verticillus ATCC15003 remains refractory to all means of introducing plasmid DNA into its cells, such as protoplastmediated transformation, transformation by electroporation, and conjugation from E. coli, in spite of exhaustive effort by us [6] and other laboratories [29] . The lack of a genetic system for S. verticillus ATCC15003 has prevented us from carrying out genetic analysis of BLM biosynthesis in vivo.
To provide additional experimental evidence to support that the cloned gene cluster encodes BLM biosynthesis, we turned to heterologous expression of the putative sugar biosynthesis genes in S. lividans to test their activities in bioconversion of the BLM aglycones into BLMs. We chose cosmid pBS9 because it harbors not only the desired sugar biosynthesis genes, blmCDEFG, but also the two BLM resistance genes, blmAB, as well as the putative ABC transporter ORF7. The latter are essential for the bioconversion experiment by providing BLM resistance to S. lividans [28] . In addition, we also cloned both the putative pathway regulator, orf30, and the transmembrane transporter, orf29, to yield pBS12. Co-introduction of both pBS9 and pBS12 into S. lividans ensures that the plasmid born genes are properly expressed in the heterologous host and that BLM will be exported out of S. lividans cells if produced (The other putative regulatory gene, orf15, is included by pBS9).
Conditions for BLM isolation, puri¢cation, and detection were ¢rst established using the wild-type organism. Fermentation of S. verticillus ATCC15003 under the standard conditions produces BLMs as a mixture of congeners, differing structurally at the C-terminal amines of the glycopeptides [24^27]. Figure 6B shows a typical pro¢le of the partially puri¢ed BLMs after Amberlite XAD-16 column upon high performance liquid chromatography (HPLC) analysis. The identities of BLM A2 and B2 were con¢rmed by HPLC co-elution with authentic standards ( Figure 6A ) and electrospray ionization^mass spectrometry (ESI^MS) analysis of the puri¢ed BLMs. Upon ESI^MS analysis, BLM A2 showed a molecular ion peak at m/z = 1414. supported by assaying their antibacterial activity against Bacillus subtilis [31] (Figure 6E ).
Both pBS9 and pBS12, as well as the vector pOJ446 as a control, were introduced into S. lividans 1326 by protoplast-mediated transformation [81] . The resulting apramycin and thiostrepton-resistant transformants S. lividans 1326 (pBS9/pBS12) were cultured in media supplemented with exogenously added aglycones of BLM A2 and B2 [82] . Transformants from the control, S. lividans 1326 (pOJ446), were cultured under identical conditions. Production of BLM A2 and B2 was analyzed by HPLC and bioassay. The isolated products from S. lividans 1326 (pBS9/pBS12) exhibited two pairs of distinctive peaks, whose identities as recovered BLM A2 and B2 aglycones and the newly synthesized BLM A2 and B2 were con¢rmed by HPLC co-elution with authentic standards (Figure 6D) . Both the BLM A2 and B2 aglycones recovered and BLM A2 and B2 synthesized were puri¢ed by HPLC and assayed for their antibacterial activity against B. subtilis [28] . As shown in Figure 6E , while the BLM aglycones were totally inactive, clear inhibition zones were detected with both the puri¢ed BLM A2 and B2 samples.
Discussion
In this report, we have localized a 140-kb contiguous DNA region, £anking the known blmAB resistance genes, from S. verticillus ATCC15003, determined 85-kb of its sequence, and established that the cloned gene cluster encodes biosynthesis of the antitumor antibiotic BLMs. The latter conclusion is based on the following results: (1) The sequenced genes are clustered with two previously characterized BLM resistance genes, blmAB. (2) The numbers and predicted substrate speci¢cities of NRPS and PKS Most of the bacterial NRPS gene clusters characterized to date are organized in operon-type structures, encoding multimodular NRPS proteins with individual modules organized along the chromosome in a linear order that parallels the order of the amino acids in the resultant peptides, i.e., following the`colinearity rule' for the NRPS-templated assembly of peptides from amino acids [1^5]. Inspection of the blm gene cluster ( Figure 2B) showed that the Blm NRPS and PKS modules apparently are not organized according to the`colinearity rule' for BLM biosynthesis ( Figure 1B ) (Exception to the`colinearity rule' was also noted for the syringomycin synthetase from Pseudomonas syringae [78] and for the exochelin synthetase from M. smegmatis [75] . In fact, Grandi and co-workers have demonstrated recently in B. subtilis that neither the operon-type structure nor the physical linkage of individual modules is essential for proper assembly and activity of the surfactin NRPS megasynthetase [79] .) Realizing that the BLM biosynthesis cannot be rationalized according to the`colinearity rule', we predicted the substrate speci¢cities of individual NRPS modules according to the speci¢city conferring codes for A domains [18] and deduced the extender unit of the PKS module according to the signature motifs of the AT domain [50] . Using the substrate speci¢city of individual NRPS and PKS modules as a guide, we were able to align the nine NRPS and one PKS modules to constitute the Blm megasynthetase ( Figure 7 ) according to our hybrid NRPS^PKS^NRPS model for BLM biosynthesis ( Figure  1B ). Although its overall structure resembles that of known NRPSs and PKSs, the Blm megasynthetase exhibits several novel features. The latter is in fact expected since the BLM backbone contains several unusual structural features, such as the L-aminoalaninamide and the pyridimidine moieties, both of which are unprecedented in peptide biosynthesis.
On the basis of the BLM structure and the deduced functions of individual NRPS and PKS domains, we propose the following model for the Blm megasynthetase-templated synthesis of BLMs. The individual modules are ¢rst primed with amino acid or carboxylic acid precursors, the substrate speci¢cities of which are determined by the A domains of the NRPS or the AT domain of PKS modules, respectively ( Figure 7) . We propose that the NRPS-4-activated Ser is further dehydrated into dehydroalanine (Dha) before its incorporation into the peptide product. Although dehydroamino acids, such as Dha, are enamines and are unlikely to be suf¢ciently stable, their stability could be improved when they are linked covalently, via a thioester bond, to the PCP domains and hence are sequestered by the protein. Dha or dehydrothreonine (Dht), also known as 2,3-dehydroaminobutyric acid, are present in many peptides, such as thiostrepton [83] , microcystin [76] , and syringomycin [78] . Although it is yet to be determined if the dehydration requires an additional enzyme, sequence analyses of both the NRPS-4 module and the NRPS modules for Dha in the microcystin cluster [76] and for Dht in the syringomycin cluster [78] showed no differences to any other typical NRPS modules.
The synthesis of the BLM peptide^polyketide backbone could start by a conjugate addition between the Ser-derived Dha on NRPS-4 module and Asn on NRPS-3 module, followed by an aminolysis to cleave the Ser^Asn adduct off the Blm megasynthetase to furnish the unusual Laminoalaninamide moiety ( Figure 8A ) (A conjugated addition to a Dha has also been proposed for the biosynthesis of the pyridine moiety of the peptide antibiotic GE2270A [83] .) The former reaction could be catalyzed by the C domain of NRPS-3 that apparently is nonfunctional for normal transpeptidation due to the lack of both His residues in the conserved HHxxxDG active site ( Figure 3C ) [39] , and the latter reaction could be catalyzed by the ALlike domain of the NRPS-5 starter module in a process that resembles the AL-catalyzed synthesis of acyl CoA from carboxylic acid but in the reverse direction in the presence of an amino donor ( Figure 3E ) [41] . Elongation resumes by NRPS-9 and NRPS-8 modules sequentially to incorporate the second Asn residue and a His residue into BLM. The isolation of P-3 from fermentation broth suggests that modi¢cations of the side chain of the second Asn residue to form the pyrimidine ring occur before the next elongation step, requiring minimally three additional steps^cycliza-tion, transamination, and desaturation. While the extra C domain, CP of NRPS-3, could serve as a candidate for the cyclase activity [39, 46, 70] , both transamination and desaturation reactions are likely catalyzed by discrete enzymes that interact with the BLM megasynthetase cooperatively. On the basis of their predicted functions, ORF18 could be a candidate for catalyzing the transamination, whereas either ORF8 or BlmF could be a candidate for catalyzing the desaturation. Although it is unclear how such enzymes would ¢t into the current models for either NRPS or PKS, similar juxtaposition between either an NRPS or a PKS and discrete modifying enzymes have been suggested for syringomycin [78] and rifamycin biosyntheses [84] , respectively.
Following the formation of the pyrimidine and incorporation of the His residue by NRPS-8 module, the peptide intermediate is further elongated by the NRPS-7 module to incorporate Ala into BLM, as evidenced by the isolation of P-3A. At this stage, the NRPS-7-bound growing peptide intermediate is transferred onto the KS domain of the BlmVIII PKS module, and elongation continues according to the chemistry of polyketide biosynthesis. Interestingly, the BlmVIII PKS module apparently furnishes the`propionate' unit in two steps by evolving a malonyl CoA-specifying AT domain coupled with an AdoMet-requiring MT domain ( Figure 8B ). This domain organization of the BlmVIII PKS module agrees well with early feeding experiments that had clearly established that the polyketide moiety of BLM was derived from an acetate and a methionine [26, 27] . Mechanistically C-methylation requires the formation of a carbanion at the K-carbon, followed by nucleophilic attack to the methyl group of AdoMet. Since the K-H is much more readily to be deprotonated in the L-ketoacyl-S-ACP than in the L-hydroxyacyl-S-ACP intermediate, one would predict that C-methylation occurs prior to L-keto reduction. The latter prediction is supported by the isolation of P-3K. It has been assumed that fungal PKSs in general contain MT domains for the introduction of a methyl branch into the polyketide products, as it has been shown recently in lovastatin biosynthesis [85] . In contrast, bacterial PKSs in general incorporate the methyl branch into the polyketide product by selecting a methyl malonyl-CoA extender unit. All PKSs from actinomycetes examined to date incorporate the alkyl branches into the resultant polyketides by selecting various alkyl malonates as the extending units that are determined by the AT domains [50] . However, a growing number of PKS genes has been discovered recently that derive the methyl branch of the polyketide products from AdoMet by a MT domain, such as the EPOS PKS for epothilone biosynthesis from Sorangium cellulosum [11, 12] and the HMWP1 PKS for yersiniabactin biosynthesis from Yersinia enterocolitica and Yersinia pestis [8, 46, 47] . Intriguingly, the stereochemistry at C-17 appears to be epimerized during the PKS-mediated elongation cycle, as indicated by the Scon¢guration in P-3A and R-con¢guration in P-4 ( Figure  1B ). It could be imagined that the epimerization occurs with the L-ketoacyl-S-ACP intermediate, as evidenced by the isolation of P-3K as a pair of (17RS)-diastereomers. The KR domain then selectively reduces the (17R)-L-ketoacyl-S-ACP, yielding (17R)-L-hydroxyacyl-S-ACP, consistent with the isolation of (17R)-P-4 exclusively. In fact, similar stereoselective reduction of a racemic L-ketoacyl intermediate has been proposed for the KR domains of both the ¢rst and second modules of the 6-deoxyerythronolide B synthase [86, 87] .
The BlmVIII PKS bound growing intermediate resumes peptide elongation by the NRPS-6 module to incorporate the Thr residue into the BLM backbone, consistent with the isolation of P-5. Before additional peptide elongation by NRPS-2, NRPS-1, and NRPS-0 modules to ¢nally yield the full length BLM peptide/polyketide/peptide backbone, the NRPS-6-bound growing intermediate apparently is modi¢ed by a C-methylation at the pyrimidine moiety, as evidenced by the isolation of P-5m. Results from early feeding experiments clearly established that this methyl group is derived from methionine, suggesting an AdoMet-dependent MT for this C-methylation reaction [26, 27] . Since no additional AdoMet-dependent MT could be identi¢ed within the sequenced blm gene cluster, the MT domain of the BlmVIII PKS could play a role in the C-methylation of the pyrimidine ring. The latter proposal deviates from the`processive' model known for both NRPS and PKS [1^5]. However, analogous juxtaposition of PKS activities for peptide modi¢cation has been proposed for yersiniabactin biosynthesis^reduction of the thiazoline ring synthesized by the HMWP2 NRPS was proposed to be catalyzed by the KR domain of the HMWP1 PKS [46, 47] .
The NRPS-2, NRPS-1, and NRPS-0 modules incorporate the L-Ala, Cys, and Cys residues, respectively, completing the assembly of the BLM backbone. In addition to typical NRPS domains, such as C, A, and PCP, for peptide elongation, these NRPS modules are characterized by the Cy (NRPS-1 and NRPS-0) [40] and Ox (NRPS-0) [11] domains as well as an inactive A domain (NRPS-0). The identi¢cation of the Cy and Ox domain in NRPS-1 and NRPS-0 modules agrees well with the unique bithiazole structure of BLMs. While thiazoline is the direct product of the Cy domain [40, 46, 47] , the thiazoline-to-thiazole conversion requires an additional oxidation step [83] . Very recently, two biosynthesis gene clusters for thiazole-containing hybrid peptide^polyketide metabolites^ the epothilone gene cluster from S. cellulosum [11, 12] and the myxothiazol gene cluster from Stigmatella aurantiaca [10] ^were characterized, and an Ox domain was proposed by Molnar and co-workers for the biosynthesis of the thiazole moiety of epothilone [11] . The A domain of the NRPS-0 module exhibits poor consensus sequence at A1, A2, A6, A7, and A10 motifs and lacks completely the A3, A4, A5, and A8 motifs ( Figure 3A) . In addition, the two invariable residues, D in A4 and K in A10 that are proposed to be essential to interact with the K-amino group and the carboxyl group for activating an K-amino acid [18] , are mutated into P in A4 and R in A10 for the NRPS-0 module, respectively. These features strongly suggests that the NRPS-0 A domain is inactive and that the loading of the NRPS-0 PCP domain is possibly catalyzed by the A domain of the upstream NRPS-1 module. Inactive domains within PKS modules are known, such as the enoylreductase domain of EPOS A and EPOS E [11] also known as EpoA and EpoF [12] . However, we are not aware of any inactive domain within an NRPS module with the possible exception of a whole module in the exochelin gene cluster [74, 75] . Loading of multiple PCPs by a single A domain has been proved for yersiniabactin biosynthesis [46, 47] .
Taken together the aforementioned structural features of the NRPS-2, -1 and -0 modules and precedence of thiazole biosynthesis in the literature, a biosynthetic pathway for the bithiazole moiety of BLMs could be proposed as shown in Figure 8C . While it cannot be excluded in the absence of any experimental data that the single Ox domain in NRPS-0 module is responsible for the oxidation of both thiazole rings, we prefer the proposed processive mechanism of Cys incorporation, cyclization, and oxidation for bithiazole biosynthesis, consistent with the lack of an Ox domain in the NRPS-1 module. The latter hypothesis is supported by the occurrence of two Ox domains for bithiazole biosynthesis observed from the myxothiazol gene cluster [10] and calls for an additional oxidase for the formation of the ¢rst thiazole ring in BLM biosynthesis. A possible candidate for this activity would be ORF8 that is highly homologous to coproporphyrinogen III oxidases [67] . In fact, a cell-free preparation from S. verticillus ATCC15003 has been reported to catalyze the conversion of phleomycins to BLMs in the presence of NAD [27] , supporting the presence of a discrete oxidase. We could imagine that the phleomycin producer results from a simple mutation at the latter oxidase gene, losing its ability to oxidize the ¢rst thiazoline ring.
Before the ¢nal release of the BLM peptide^polyketide backbone from the BLM megasynthetase, the L-position of the His residue is hydroxylated, providing the glycosidic linkage for the two sugars found in BLMs. Both ORF1, suggested early by Calcutt and Schmidt in characterizing the blmAB resistance locus [29] and BlmF show signi¢cant sequence homology to amino acid L-hydroxylases, serving as candidates for catalyzing this hydroxylation. The isolation of both P-6m and P-6mo in the form of free carboxylic acid suggests that L-hydroxylation of the His residue takes place after the complete assembly of the BLM peptidep olyketide backbone but before its release from the BLM megasynthetase upon nucleophilic attack by the terminal amines.
Most of the NRPSs and PKSs studied to date release the full length peptide or polyketide intermediate from enzyme complexes by the catalysis of a thioesterase (TE) domain that is usually found at the distal C-terminus of the NRPS or PKS protein [1^3] . The BLMs are characterized by an unique terminal amide moiety, differing structurally from other well characterized peptide or polyketide metabolites. Myxothiazol [10] and rifamycin [88] are the only two other peptide and polyketide metabolites with a terminal amide structure, whose biosynthetic gene clusters have been characterized. Although a TE domain is identi¢ed at the distal C-terminus of the proposed Mta NRPSP KS hybrid enzyme complex, the amino group of myxothiazol terminal amide is proposed to be derived from an amino acid by the action of MtaG, an NRPS module with an unprecedented monooxygenase domain [10] . The latter domain catalyzes the oxidative cleavage at the K-position of the last amino acid of the full length peptide^polyketide intermediate to afford the terminal amide of myxothiazol, and this mechanism is proposed to be a general strategy for the formation of terminal amides in other peptide or polyketide metabolites [10] . In contrast, the Rif PKS gene clearly lacks a TE domain. Associated with the Rif PKS, instead, is a discrete protein RifF, an amide synthase [88] . The latter enzyme was proposed to catalyze the release of the complete polyketide from the PKS by intramolecular amide formation to generate the macrocyclic lactam structure in rifamycin biosynthesis, representing another mechanism for the amide formation in peptide and polyketide biosynthesis [88] . The formation of the amide moiety of BLMs is apparently distinct from both the typical peptide or polyketide biosynthesis and myxothiazol or rifamycin biosynthesis. Neither TE domain, unusual NRPS module with a monooxygenase domain, nor discrete amide synthase has been identi¢ed within the sequenced blm gene cluster. These ¢ndings, in fact, are consistent with early feeding experiments that clearly established that various amines can be incorporated into the C-terminal amine moiety of BLMs [24^27], excluding the amino acid origin of the terminal amino group, as has been proposed for myxothiazol biosynthesis [10] . In addition, over 40 different amines have been incorporated into BLMs by directed biosynthesis [24^27] , suggesting that the enzyme activity responsible for the amide formation must have exhibited a very broad substrate speci¢city for the amine. Interestingly, £anking the modular blm NRPS and PKS genes are two orfs, blmXI and blmII, whose deduced products are highly homologous to the C domain of modular NRPS ( Figure  3C ). On the basis of the analogous chemistry, these discrete condensation enzymes could serve as candidates catalyzing the release of the full length BLM peptide^poly-ketide backbone from the BLM megasynthetase complex by nucleophilic attack of the RCO-S-PCP species with an amine to generate the BLM amide structure, providing yet another mechanism for amide formation in peptide and polyketide biosynthesis. C domain-catalyzed release of either a RCO-S-PCP from NRPS or RCO-S-ACP from PKS has, in fact, been proposed for rapamycin [7] and lovastatin [85] biosynthesis, respectively.
The attachment of the two unusual sugars^L-gulose and 3-O-carbamoyl-D-mannose^to the BLM aglycones ¢nally completes the biosynthesis of BLMs. On the basis of the sequenced sugar biosynthesis genes and their deduced functions, the following pathway could be proposed for the biosyntheses of both sugars from D-mannose-phosphate ( Figure 9 ). The exact order for individual reactions to make these modi¢ed sugars and for glycosylations to attach the sugars to the BLM aglycones has to be determined by future experiments.
Among all the NRPSs, PKSs, and hybrid NRPS^PKS systems examined so far, the Blm megasynthetase consists of the largest number of individual proteins. The precise interactions among all the Blm NRPS and Blm PKS proteins to constitute the Blm megasynthetase complex, as well as other discrete proteins juxtaposed with the BLM megasynthetase complex to modify the growing BLM intermediates, therefore, re£ect a remarkable power of protein^pro-tein recognition. Although we are yet to provide direct evidence supporting the speci¢c protein^protein interactions between the neighboring proteins, it is striking to note that all the biosynthetic intermediates isolated are derailed from either NRPS or PKS modules at the junctions between the interacting proteins ( Figure 7 ). Since it is not dif¢cult to imagine that an intermediate is more likely to fall off the enzyme complex when it is subjected to interpeptide transfer than to intrapeptide transfer, we view the latter observation as a strong evidence supporting the current model of the Blm megasynthetase.
The biosynthesis of natural products of hybrid peptidep olyketide origin provides an excellent opportunity to investigate intermodular communication between NRPS and PKS modules and to elucidate the mechanism of constructing hybrid NRPS^PKS systems for expanding the size and diversity of`unnatural' natural product libraries [2, 3, 6] . In addition to the blm cluster described in this report, a growing number of gene clusters for hybrid peptide^polyketide biosynthesis have been characterized recently, which includes the EPOS synthetase [11] ^also known as Epo synthetase [12] ^for epothilones from S. cellulosum, the Mta synthetase for myxothiazol from S. aurantiaca [10] , the Rap synthetase from Streptomyces hygroscopicus [7, 89] , the Ta1 synthetase for antibiotic TA from M. xanthus [9] , and the HMWPs for yersiniabactin from Y. enterocolitica and Y. pestis [8, 46, 47] . Detailed comparison of individual domains or modules between hybrid and non-hybrid systems could shed light on the mechanism for the altered catalytic activities and intermodular communication between the interacting NRPS and PKS modules to constitute hybrid enzymes.
The BlmIX/BlmVIII/BlmVII system combines the features of both hybrid NRPS/PKS and PKS/NRPS systems. The fact that both the BlmIX and BlmVII NRPS modules and the BlmVIII PKS module are three separate proteins with a typical domain organization for NRPS and PKS enzymes greatly simpli¢es the mechanistic analysis of the hybrid NRPS/PKS/NRPS complex. We have found that the KS domain of BlmVIII is more similar to the KSs known to interact with NRPS modules in hybrid NRPS/PKS systems than to KSs of type I PKSs. We attribute these subtle differences to their unique reactivity that catalyzes the transfer of the peptidyl intermediate from the PCP to the KS domain, which presumably takes place prior to chain elongation. Subsequent condensation catalyzed by the KS domain between the peptidyl intermediate and malonyl-S-ACP results in the elongation of the growing peptide with a carboxylic acid. Equally striking are the discoveries that the ACP domain of BlmVIII is more similar to a PCP than to an ACP and that the C domain of BlmVII has an additional N-terminal segment of about 50 amino acids that is rich in arginine, aspartic acid, and glutamic acid. The latter feature is analogous to the N-terminal interpolypeptide linker for type I PKS, which has recently been demonstrated to play a critical role in intermodular communication [20] . These unique features of the ACP domain from the BlmVIII PKS module and the C domain from the BlmVII NRPS module could provide the molecular basis for the C domain to recognize the acyl-S-ACP as a substrate. Subsequent condensation catalyzed by the C domain between acyl-S-ACP and amino acyl-S-PCP results in the elongation of the growing polyketide (as far as this condensation is concerned) with an amino acid. Although answers to many of these questions may ultimately have to come from in vitro biochemical investigations, the availability of the blm gene cluster has now set the stage for such future studies.
Signi¢cance
The anticancer antibiotic BLM has been incorporated into chemotherapy of several malignancies under the trade name of Blenoxane 0 0 since the late 1970s. However, wide application of this drug has been prevented by early development of drug resistance and dose-limiting pulmonary toxicity. Attempts at analog development to circumvent these limitations have been hampered by the structural complexity of the naturally available BLMs. Complementary to making microbial metabolites and their structural analogs by chemical synthesis, genetic manipulation of genes governing secondary metabolism offers a promising alternative to prepare these compounds biosynthetically. This work represents a complete characterization of the gene cluster for BLM production in S. verticillus ATCC15003, which consists of 10 NRPS genes, one PKS genes, ¢ve sugar biosynthesis genes, as well as genes encoding other biosynthesis, resistance, and regulatory proteins. The availability of the blm gene cluster should facilitate future attempts, using combinatorial biosynthesis and rational metabolic pathway engineering, to produce novel BLM analogs with improved therapeutic ef¢cacy and lower toxicity as antitumor agents.
The structural and catalytic similarities between modular NRPS and PKS inspired us to search for a hybrid NRPSP KS system. The fact that individual domains and modules of both NRPS and PKS are considerably tolerant towards genetic engineering supports the wisdom of combining individual NRPS and PKS modules for combinatorial biosynthesis. A great challenge in constructing a hybrid NRPS^PKS system lies at revealing the molecular basis for intermodular communication between NRPS and PKS. This issue can now be investigated in detail through experiments using the blm NRPS and PKS genes since they constitute a natural hybrid NRPS^PKS. In addition, characterization of the BLM megasynthetase should also enable us to de¢ne the mechanism for thiazole biosynthesis, potentially leading to the making of novel thiazole-containing molecules by engineering peptide biosynthesis.
Materials and methods

General procedures
E. coli DH5K [90] , E. coli XL 1-Blue MR (Stratagene, La Jolla, CA, USA), E. coli BL21(DE-3) (Novagen, Madison, WI, USA), B. subtilis PB2 (Prof. Chet Price, University of California, Davis, CA, USA), S. lividans 1326 [81] , and S. verticillus ATCC15003 (American Type Culture Collection, Rockville, MD, USA) were used in this work. pWHM3 [91] and pOJ446 [34] were described previously, and pQE60 (Qiagen, Santa Clarita, CA, USA), pET28a and pET29a (Novagen) were from commercial sources. BLM A2 and B2 were gifts from Prof. Claude F. Meares, University of California, Davis. The BLM A2 and B2 aglycones were prepared from BLM A2 and B2 according to a literature procedure [82] .
Plasmid preparation was carried out by using commercial kits (Qiagen). Total S. verticillus ATCC15003 DNA was isolated according to literature protocols [81, 92] . Restriction enzymes and other molecular biology reagents were from commercial sources, and digestion and ligation followed standard methods [90] . For Southern analysis, digoxigenin labelling of DNA probes, hybridization, and detection were performed according to the protocols provided by the manufacturer (Boehringer Mannheim Biochemicals, Indianapolis, IN, USA). Cloning and sequencing of the blm gene cluster A genomic library of S. verticillus ATCC15003 was constructed in pOJ446 according to literature procedures [92] and screened with probes made from both ends of the blmAB locus [29] , leading to the localization of 140-kb contiguous DNA, of which 100 kb is upstream and 40 kb is downstream of the blmAB genes (Figure 2A) . Heterologous NRPS probes, ampli¢ed from S. verticillus ATCC15003 by polymerase chain reaction (PCR) according to literature procedures, were described previously and were used to screen the entire 140-kb DNA by Southern analysis under various hybridization conditions [6] . The DNA sequence reported in this work was determined from pBS5, pBS6, and pBS8.
Overproduction and biochemical characterization of the NRPS-1A and NRPS-6A proteins Heterologous expression of the A domains in E. coli were performed according to literature procedures [36, 94] . NRPS-1A (forward primer 5P-AACCCATGGCTGCTTCCCTGACCCGCCTGGCC-3P (the NcoI site is underlined) and reverse primer 5P-CCTAGATCTACGGGCAGGTGG-GGCGGT-3P (the BglII site is underlined)) and NRPS-6A (forward primer 5P-GGGAATTCCATATGATCCTCACGTCCTTCCAC-3P (the NdeI site is underlined) and reverse primer 5P-GGCAAGCTTGGGTGAGGGTCCG-TTCGGT-3P (the HindIII site is underlined)) were ampli¢ed by PCR from S. verticillus ATCC15003 cosmid clones. The resulting 1.6-kb fragment of NRPS-1A was ¢rst cloned into the NcoI^BglII sites of pQE60 and then moved as an NcoI^HindIII fragment into the similar sites of pET29a to yield pBS13, and the resulting 1.6-kb fragment of NRPS-6A was directly cloned into the NdeI^HindIII sites of pET28a to yield pBS14. Introduction of pBS13 and pBS14 into E. coli BL21(DE-3) under standard expression conditions resulted in production of NRPS-1A (with an N-terminal S-tag and a C-terminal His 6 -tag) and NRPS-6A (with an Nterminal His 6 -tag), respectively. The soluble fractions of fusion proteins were subjected sequentially to an af¢nity chromatography on Ni^NTA resin and an anion exchange chromatography on a Hyper-D column (PerSeptive Biosystem, Framingham, MA, USA), resulting in NRPS-1A and NRPS-6A with near homogeneity. Amino acid-dependent ATP^PPi assays were performed essentially according to the literature procedures [36] .
Production and determination of BLM production
Spore stock of S. verticillus ATCC15003 was inoculated to the seed medium (25 ml), consisting of 1% glucose, 1% starch, 0.75% peptone, 0.75% beef extract, and 0.3% NaCl, pH 7.0, and incubated at 30³C, 300 rpm for 38 h. The seed inoculum (5 ml) was then added to the production medium (50 ml), consisting of 6.4% milet jelly, 0.5% glucose, 3.5% soybean meal, 0.75% cornsteep liquor, 0.2% NaNO 3 , 0.3% NaCl, 0.1% K 2 HPO 4 , 0.05% ZnSO 4 W7H 2 O, 0.01% CuSO 4 W5H 2 O, and incubated at 30³C, 300 rpm for 6 days [24^27].
The fermentation broth was extracted with EtOAc, and the aqueous phase, which contains BLMs, was loaded to an Amberlite XD-16 column. After extensive wash with H 2 O, BLMs were eluted with MeOH0
.01 N HCl (4:1, vol/vol). The elute was concentrated in vacuo, re-dissolved in 50% aqueous MeOH, and subjected to HPLC analysis on an Altima C-18 column (5 Wm, 250U4.6 mm, Alltech Associates, Deer¢eld, IL, USA). The column was equilibrated with 1% NH 4 OAc buffer, pH 5.7, with 20% MeOH (vol/vol) and developed with a 20-min linear gradient from 20 to 70% MeOH in the same NH 4 OAc buffer, at a £ow rate of 0.8 ml/min with UV^Vis detection at 300 nm on a Dynamax gradient HPLC system (Rainin, Walnut Creek, CA, USA).
ESI^MS determination was performed on an LCQ-Decca mass spectrometer (ThermoQuest, San Jose, CA, USA) at the Cancer Center, University of California, Davis. To assay the antibacterial activity of BLMs, B. subtilis PB2 was used as the test organism [28] . B. subtilis PB2 was grown overnight at 37³C in TSB [81] , and the resulting culture was diluted (1:100) in 50% glycerol and stored in aliquots at 320³C. For bioassay, liquid samples (150 Wl) were added to stainless steel cylinders placed on agar plates of TSB at half nutrient concentration pre-seeded with the B. subtilis PB2 glycerol stock (0.15% vol/vol) [95] . The plates were incubated at 37³C overnight to determine sizes of the inhibition zones.
Bioconversion of BLM aglycones into BLMs in S. lividans
A 3.4-kb BamHI fragment, containing the putative pathway regulator orf30 and transmembrane transporter orf29, was cloned into the same sites of pWHM3 to yield pBS12. Both pBS9 and pBS12 were introduced into S. lividans 1326 by protoplast-mediated co-transformation, with both apramycin (25 Wg/ml) and thiostrepton (5 Wg/ml) selection [81] . pOJ446 was similarly introduced into S. lividans 1326 as a control, selected with apramycin. The resultant transformants, S. lividans 1326 (pBS9/pBS12) and S. lividans 1326 (pOJ446), were grown in R2YE medium [81] containing appropriate antibiotics, respectively, and incubated at 30³C, 300 rpm for 3 days. A sterile solution of the BLM aglycones was then added (¢nal concentration 33^160 Wg/ml), and the resulting culture was incubated for additional 7 days. Isolation, puri¢cation, and identi¢cation of both the BLM aglycones and BLMs from S. lividans 1326 (pBS9/pBS12) and S. lividans 1326 (pOJ446) were carried out similarly as described for S. verticillus ATCC15003.
Accession numbers
The entire sequence of the gene cluster for BLM production in S. verticillus ATCC15003 has been deposited into GenBank under accession numbers AF149091 and AF210249.
